0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNase I Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-24F18801
Home | Market Reports | Science
Global DNase I Market Research Report 2025
BUY CHAPTERS

Global DNase I Market Research Report 2025

Code: QYRE-Auto-24F18801
Report
March 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

DNase I Market Size

The global market for DNase I was valued at US$ 1036 million in the year 2024 and is projected to reach a revised size of US$ 1883 million by 2031, growing at a CAGR of 8.9% during the forecast period.

DNase I Market

DNase I Market

DNase I (Deoxyribonuclease I) is a specific type of DNase enzyme that hydrolyzes (breaks down) DNA by cleaving the phosphodiester bonds between the nucleotides in the DNA backbone. It is one of the most well-known and widely used DNases in both biological processes and laboratory applications.
North American market for DNase I is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for DNase I is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of DNase I include Roche, Sigma-Aldrich, Thermo Fisher Scientific, Zymo Research, Takara Bio, Biomatik, Novus Biologicals, Cell Sciences, Promega, RayBiotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DNase I, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNase I.
The DNase I market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNase I market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNase I manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DNase I Market Report

Report Metric Details
Report Name DNase I Market
Accounted market size in year US$ 1036 million
Forecasted market size in 2031 US$ 1883 million
CAGR 8.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Medical
  • Molecular Biology
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Sigma-Aldrich, Thermo Fisher Scientific, Zymo Research, Takara Bio, Biomatik, Novus Biologicals, Cell Sciences, Promega, RayBiotech, Creative Enzymes, Creative Diagnostics, Aladdin Scientific, MyBioSource, Worthington Biochemical Corporation, New England Biolabs, Creative BioMart, Cell Signaling Technology, Abbexa
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of DNase I manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of DNase I in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is DNase I Market growing?

Ans: The DNase I Market witnessing a CAGR of 8.9% during the forecast period 2025-2031.

What is the DNase I Market size in 2031?

Ans: The DNase I Market size in 2031 will be US$ 1883 million.

Who are the main players in the DNase I Market report?

Ans: The main players in the DNase I Market are Roche, Sigma-Aldrich, Thermo Fisher Scientific, Zymo Research, Takara Bio, Biomatik, Novus Biologicals, Cell Sciences, Promega, RayBiotech, Creative Enzymes, Creative Diagnostics, Aladdin Scientific, MyBioSource, Worthington Biochemical Corporation, New England Biolabs, Creative BioMart, Cell Signaling Technology, Abbexa

What are the Application segmentation covered in the DNase I Market report?

Ans: The Applications covered in the DNase I Market report are Medical, Molecular Biology

What are the Type segmentation covered in the DNase I Market report?

Ans: The Types covered in the DNase I Market report are Animal Sources, Microbial Sources

Recommended Reports

DNA Analysis Tools

Gene Therapy Markets

DNA Preparation Kits

1 DNase I Market Overview
1.1 Product Definition
1.2 DNase I by Type
1.2.1 Global DNase I Market Value Comparison by Type (2024 VS 2031)
1.2.2 Animal Sources
1.2.3 Microbial Sources
1.3 DNase I by Application
1.3.1 Global DNase I Market Value by Application (2024 VS 2031)
1.3.2 Medical
1.3.3 Molecular Biology
1.4 Global DNase I Market Size Estimates and Forecasts
1.4.1 Global DNase I Revenue 2020-2031
1.4.2 Global DNase I Sales 2020-2031
1.4.3 Global DNase I Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 DNase I Market Competition by Manufacturers
2.1 Global DNase I Sales Market Share by Manufacturers (2020-2025)
2.2 Global DNase I Revenue Market Share by Manufacturers (2020-2025)
2.3 Global DNase I Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of DNase I, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DNase I, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DNase I, Product Type & Application
2.7 Global Key Manufacturers of DNase I, Date of Enter into This Industry
2.8 Global DNase I Market Competitive Situation and Trends
2.8.1 Global DNase I Market Concentration Rate
2.8.2 The Global 5 and 10 Largest DNase I Players Market Share by Revenue
2.8.3 Global DNase I Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DNase I Market Scenario by Region
3.1 Global DNase I Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global DNase I Sales by Region: 2020-2031
3.2.1 Global DNase I Sales by Region: 2020-2025
3.2.2 Global DNase I Sales by Region: 2026-2031
3.3 Global DNase I Revenue by Region: 2020-2031
3.3.1 Global DNase I Revenue by Region: 2020-2025
3.3.2 Global DNase I Revenue by Region: 2026-2031
3.4 North America DNase I Market Facts & Figures by Country
3.4.1 North America DNase I Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America DNase I Sales by Country (2020-2031)
3.4.3 North America DNase I Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe DNase I Market Facts & Figures by Country
3.5.1 Europe DNase I Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe DNase I Sales by Country (2020-2031)
3.5.3 Europe DNase I Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DNase I Market Facts & Figures by Region
3.6.1 Asia Pacific DNase I Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific DNase I Sales by Region (2020-2031)
3.6.3 Asia Pacific DNase I Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America DNase I Market Facts & Figures by Country
3.7.1 Latin America DNase I Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America DNase I Sales by Country (2020-2031)
3.7.3 Latin America DNase I Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa DNase I Market Facts & Figures by Country
3.8.1 Middle East and Africa DNase I Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa DNase I Sales by Country (2020-2031)
3.8.3 Middle East and Africa DNase I Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DNase I Sales by Type (2020-2031)
4.1.1 Global DNase I Sales by Type (2020-2025)
4.1.2 Global DNase I Sales by Type (2026-2031)
4.1.3 Global DNase I Sales Market Share by Type (2020-2031)
4.2 Global DNase I Revenue by Type (2020-2031)
4.2.1 Global DNase I Revenue by Type (2020-2025)
4.2.2 Global DNase I Revenue by Type (2026-2031)
4.2.3 Global DNase I Revenue Market Share by Type (2020-2031)
4.3 Global DNase I Price by Type (2020-2031)
5 Segment by Application
5.1 Global DNase I Sales by Application (2020-2031)
5.1.1 Global DNase I Sales by Application (2020-2025)
5.1.2 Global DNase I Sales by Application (2026-2031)
5.1.3 Global DNase I Sales Market Share by Application (2020-2031)
5.2 Global DNase I Revenue by Application (2020-2031)
5.2.1 Global DNase I Revenue by Application (2020-2025)
5.2.2 Global DNase I Revenue by Application (2026-2031)
5.2.3 Global DNase I Revenue Market Share by Application (2020-2031)
5.3 Global DNase I Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche DNase I Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche DNase I Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Sigma-Aldrich
6.2.1 Sigma-Aldrich Company Information
6.2.2 Sigma-Aldrich Description and Business Overview
6.2.3 Sigma-Aldrich DNase I Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sigma-Aldrich DNase I Product Portfolio
6.2.5 Sigma-Aldrich Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific DNase I Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Thermo Fisher Scientific DNase I Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Zymo Research
6.4.1 Zymo Research Company Information
6.4.2 Zymo Research Description and Business Overview
6.4.3 Zymo Research DNase I Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zymo Research DNase I Product Portfolio
6.4.5 Zymo Research Recent Developments/Updates
6.5 Takara Bio
6.5.1 Takara Bio Company Information
6.5.2 Takara Bio Description and Business Overview
6.5.3 Takara Bio DNase I Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takara Bio DNase I Product Portfolio
6.5.5 Takara Bio Recent Developments/Updates
6.6 Biomatik
6.6.1 Biomatik Company Information
6.6.2 Biomatik Description and Business Overview
6.6.3 Biomatik DNase I Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biomatik DNase I Product Portfolio
6.6.5 Biomatik Recent Developments/Updates
6.7 Novus Biologicals
6.7.1 Novus Biologicals Company Information
6.7.2 Novus Biologicals Description and Business Overview
6.7.3 Novus Biologicals DNase I Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novus Biologicals DNase I Product Portfolio
6.7.5 Novus Biologicals Recent Developments/Updates
6.8 Cell Sciences
6.8.1 Cell Sciences Company Information
6.8.2 Cell Sciences Description and Business Overview
6.8.3 Cell Sciences DNase I Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cell Sciences DNase I Product Portfolio
6.8.5 Cell Sciences Recent Developments/Updates
6.9 Promega
6.9.1 Promega Company Information
6.9.2 Promega Description and Business Overview
6.9.3 Promega DNase I Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Promega DNase I Product Portfolio
6.9.5 Promega Recent Developments/Updates
6.10 RayBiotech
6.10.1 RayBiotech Company Information
6.10.2 RayBiotech Description and Business Overview
6.10.3 RayBiotech DNase I Sales, Revenue and Gross Margin (2020-2025)
6.10.4 RayBiotech DNase I Product Portfolio
6.10.5 RayBiotech Recent Developments/Updates
6.11 Creative Enzymes
6.11.1 Creative Enzymes Company Information
6.11.2 Creative Enzymes Description and Business Overview
6.11.3 Creative Enzymes DNase I Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Creative Enzymes DNase I Product Portfolio
6.11.5 Creative Enzymes Recent Developments/Updates
6.12 Creative Diagnostics
6.12.1 Creative Diagnostics Company Information
6.12.2 Creative Diagnostics Description and Business Overview
6.12.3 Creative Diagnostics DNase I Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Creative Diagnostics DNase I Product Portfolio
6.12.5 Creative Diagnostics Recent Developments/Updates
6.13 Aladdin Scientific
6.13.1 Aladdin Scientific Company Information
6.13.2 Aladdin Scientific Description and Business Overview
6.13.3 Aladdin Scientific DNase I Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aladdin Scientific DNase I Product Portfolio
6.13.5 Aladdin Scientific Recent Developments/Updates
6.14 MyBioSource
6.14.1 MyBioSource Company Information
6.14.2 MyBioSource Description and Business Overview
6.14.3 MyBioSource DNase I Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MyBioSource DNase I Product Portfolio
6.14.5 MyBioSource Recent Developments/Updates
6.15 Worthington Biochemical Corporation
6.15.1 Worthington Biochemical Corporation Company Information
6.15.2 Worthington Biochemical Corporation Description and Business Overview
6.15.3 Worthington Biochemical Corporation DNase I Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Worthington Biochemical Corporation DNase I Product Portfolio
6.15.5 Worthington Biochemical Corporation Recent Developments/Updates
6.16 New England Biolabs
6.16.1 New England Biolabs Company Information
6.16.2 New England Biolabs Description and Business Overview
6.16.3 New England Biolabs DNase I Sales, Revenue and Gross Margin (2020-2025)
6.16.4 New England Biolabs DNase I Product Portfolio
6.16.5 New England Biolabs Recent Developments/Updates
6.17 Creative BioMart
6.17.1 Creative BioMart Company Information
6.17.2 Creative BioMart Description and Business Overview
6.17.3 Creative BioMart DNase I Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Creative BioMart DNase I Product Portfolio
6.17.5 Creative BioMart Recent Developments/Updates
6.18 Cell Signaling Technology
6.18.1 Cell Signaling Technology Company Information
6.18.2 Cell Signaling Technology Description and Business Overview
6.18.3 Cell Signaling Technology DNase I Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Cell Signaling Technology DNase I Product Portfolio
6.18.5 Cell Signaling Technology Recent Developments/Updates
6.19 Abbexa
6.19.1 Abbexa Company Information
6.19.2 Abbexa Description and Business Overview
6.19.3 Abbexa DNase I Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Abbexa DNase I Product Portfolio
6.19.5 Abbexa Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DNase I Industry Chain Analysis
7.2 DNase I Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DNase I Production Mode & Process Analysis
7.4 DNase I Sales and Marketing
7.4.1 DNase I Sales Channels
7.4.2 DNase I Distributors
7.5 DNase I Customer Analysis
8 DNase I Market Dynamics
8.1 DNase I Industry Trends
8.2 DNase I Market Drivers
8.3 DNase I Market Challenges
8.4 DNase I Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global DNase I Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global DNase I Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global DNase I Market Competitive Situation by Manufacturers in 2024
 Table 4. Global DNase I Sales (g) of Key Manufacturers (2020-2025)
 Table 5. Global DNase I Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global DNase I Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global DNase I Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market DNase I Average Price (US$/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of DNase I, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of DNase I, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of DNase I, Product Type & Application
 Table 12. Global Key Manufacturers of DNase I, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global DNase I by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNase I as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global DNase I Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global DNase I Sales by Region (2020-2025) & (g)
 Table 18. Global DNase I Sales Market Share by Region (2020-2025)
 Table 19. Global DNase I Sales by Region (2026-2031) & (g)
 Table 20. Global DNase I Sales Market Share by Region (2026-2031)
 Table 21. Global DNase I Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global DNase I Revenue Market Share by Region (2020-2025)
 Table 23. Global DNase I Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global DNase I Revenue Market Share by Region (2026-2031)
 Table 25. North America DNase I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America DNase I Sales by Country (2020-2025) & (g)
 Table 27. North America DNase I Sales by Country (2026-2031) & (g)
 Table 28. North America DNase I Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America DNase I Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe DNase I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe DNase I Sales by Country (2020-2025) & (g)
 Table 32. Europe DNase I Sales by Country (2026-2031) & (g)
 Table 33. Europe DNase I Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe DNase I Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific DNase I Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific DNase I Sales by Region (2020-2025) & (g)
 Table 37. Asia Pacific DNase I Sales by Region (2026-2031) & (g)
 Table 38. Asia Pacific DNase I Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific DNase I Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DNase I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America DNase I Sales by Country (2020-2025) & (g)
 Table 42. Latin America DNase I Sales by Country (2026-2031) & (g)
 Table 43. Latin America DNase I Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America DNase I Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa DNase I Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa DNase I Sales by Country (2020-2025) & (g)
 Table 47. Middle East and Africa DNase I Sales by Country (2026-2031) & (g)
 Table 48. Middle East and Africa DNase I Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa DNase I Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global DNase I Sales (g) by Type (2020-2025)
 Table 51. Global DNase I Sales (g) by Type (2026-2031)
 Table 52. Global DNase I Sales Market Share by Type (2020-2025)
 Table 53. Global DNase I Sales Market Share by Type (2026-2031)
 Table 54. Global DNase I Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global DNase I Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global DNase I Revenue Market Share by Type (2020-2025)
 Table 57. Global DNase I Revenue Market Share by Type (2026-2031)
 Table 58. Global DNase I Price (US$/g) by Type (2020-2025)
 Table 59. Global DNase I Price (US$/g) by Type (2026-2031)
 Table 60. Global DNase I Sales (g) by Application (2020-2025)
 Table 61. Global DNase I Sales (g) by Application (2026-2031)
 Table 62. Global DNase I Sales Market Share by Application (2020-2025)
 Table 63. Global DNase I Sales Market Share by Application (2026-2031)
 Table 64. Global DNase I Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global DNase I Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global DNase I Revenue Market Share by Application (2020-2025)
 Table 67. Global DNase I Revenue Market Share by Application (2026-2031)
 Table 68. Global DNase I Price (US$/g) by Application (2020-2025)
 Table 69. Global DNase I Price (US$/g) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Roche DNase I Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Sigma-Aldrich Company Information
 Table 76. Sigma-Aldrich Description and Business Overview
 Table 77. Sigma-Aldrich DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. Sigma-Aldrich DNase I Product
 Table 79. Sigma-Aldrich Recent Developments/Updates
 Table 80. Thermo Fisher Scientific Company Information
 Table 81. Thermo Fisher Scientific Description and Business Overview
 Table 82. Thermo Fisher Scientific DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Thermo Fisher Scientific DNase I Product
 Table 84. Thermo Fisher Scientific Recent Developments/Updates
 Table 85. Zymo Research Company Information
 Table 86. Zymo Research Description and Business Overview
 Table 87. Zymo Research DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. Zymo Research DNase I Product
 Table 89. Zymo Research Recent Developments/Updates
 Table 90. Takara Bio Company Information
 Table 91. Takara Bio Description and Business Overview
 Table 92. Takara Bio DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Takara Bio DNase I Product
 Table 94. Takara Bio Recent Developments/Updates
 Table 95. Biomatik Company Information
 Table 96. Biomatik Description and Business Overview
 Table 97. Biomatik DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. Biomatik DNase I Product
 Table 99. Biomatik Recent Developments/Updates
 Table 100. Novus Biologicals Company Information
 Table 101. Novus Biologicals Description and Business Overview
 Table 102. Novus Biologicals DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 103. Novus Biologicals DNase I Product
 Table 104. Novus Biologicals Recent Developments/Updates
 Table 105. Cell Sciences Company Information
 Table 106. Cell Sciences Description and Business Overview
 Table 107. Cell Sciences DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 108. Cell Sciences DNase I Product
 Table 109. Cell Sciences Recent Developments/Updates
 Table 110. Promega Company Information
 Table 111. Promega Description and Business Overview
 Table 112. Promega DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 113. Promega DNase I Product
 Table 114. Promega Recent Developments/Updates
 Table 115. RayBiotech Company Information
 Table 116. RayBiotech Description and Business Overview
 Table 117. RayBiotech DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 118. RayBiotech DNase I Product
 Table 119. RayBiotech Recent Developments/Updates
 Table 120. Creative Enzymes Company Information
 Table 121. Creative Enzymes Description and Business Overview
 Table 122. Creative Enzymes DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 123. Creative Enzymes DNase I Product
 Table 124. Creative Enzymes Recent Developments/Updates
 Table 125. Creative Diagnostics Company Information
 Table 126. Creative Diagnostics Description and Business Overview
 Table 127. Creative Diagnostics DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 128. Creative Diagnostics DNase I Product
 Table 129. Creative Diagnostics Recent Developments/Updates
 Table 130. Aladdin Scientific Company Information
 Table 131. Aladdin Scientific Description and Business Overview
 Table 132. Aladdin Scientific DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 133. Aladdin Scientific DNase I Product
 Table 134. Aladdin Scientific Recent Developments/Updates
 Table 135. MyBioSource Company Information
 Table 136. MyBioSource Description and Business Overview
 Table 137. MyBioSource DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 138. MyBioSource DNase I Product
 Table 139. MyBioSource Recent Developments/Updates
 Table 140. Worthington Biochemical Corporation Company Information
 Table 141. Worthington Biochemical Corporation Description and Business Overview
 Table 142. Worthington Biochemical Corporation DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 143. Worthington Biochemical Corporation DNase I Product
 Table 144. Worthington Biochemical Corporation Recent Developments/Updates
 Table 145. New England Biolabs Company Information
 Table 146. New England Biolabs Description and Business Overview
 Table 147. New England Biolabs DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 148. New England Biolabs DNase I Product
 Table 149. New England Biolabs Recent Developments/Updates
 Table 150. Creative BioMart Company Information
 Table 151. Creative BioMart Description and Business Overview
 Table 152. Creative BioMart DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 153. Creative BioMart DNase I Product
 Table 154. Creative BioMart Recent Developments/Updates
 Table 155. Cell Signaling Technology Company Information
 Table 156. Cell Signaling Technology Description and Business Overview
 Table 157. Cell Signaling Technology DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 158. Cell Signaling Technology DNase I Product
 Table 159. Cell Signaling Technology Recent Developments/Updates
 Table 160. Abbexa Company Information
 Table 161. Abbexa Description and Business Overview
 Table 162. Abbexa DNase I Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 163. Abbexa DNase I Product
 Table 164. Abbexa Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. DNase I Distributors List
 Table 168. DNase I Customers List
 Table 169. DNase I Market Trends
 Table 170. DNase I Market Drivers
 Table 171. DNase I Market Challenges
 Table 172. DNase I Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of DNase I
 Figure 2. Global DNase I Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DNase I Market Share by Type: 2024 & 2031
 Figure 4. Animal Sources Product Picture
 Figure 5. Microbial Sources Product Picture
 Figure 6. Global DNase I Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global DNase I Market Share by Application: 2024 & 2031
 Figure 8. Medical
 Figure 9. Molecular Biology
 Figure 10. Global DNase I Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global DNase I Market Size (2020-2031) & (US$ Million)
 Figure 12. Global DNase I Sales (2020-2031) & (g)
 Figure 13. Global DNase I Average Price (US$/g) & (2020-2031)
 Figure 14. DNase I Report Years Considered
 Figure 15. DNase I Sales Share by Manufacturers in 2024
 Figure 16. Global DNase I Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest DNase I Players: Market Share by Revenue in DNase I in 2024
 Figure 18. DNase I Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global DNase I Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America DNase I Sales Market Share by Country (2020-2031)
 Figure 21. North America DNase I Revenue Market Share by Country (2020-2031)
 Figure 22. United States DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe DNase I Sales Market Share by Country (2020-2031)
 Figure 25. Europe DNase I Revenue Market Share by Country (2020-2031)
 Figure 26. Germany DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific DNase I Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific DNase I Revenue Market Share by Region (2020-2031)
 Figure 33. China DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America DNase I Sales Market Share by Country (2020-2031)
 Figure 41. Latin America DNase I Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa DNase I Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa DNase I Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE DNase I Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of DNase I by Type (2020-2031)
 Figure 52. Global Revenue Market Share of DNase I by Type (2020-2031)
 Figure 53. Global DNase I Price (US$/g) by Type (2020-2031)
 Figure 54. Global Sales Market Share of DNase I by Application (2020-2031)
 Figure 55. Global Revenue Market Share of DNase I by Application (2020-2031)
 Figure 56. Global DNase I Price (US$/g) by Application (2020-2031)
 Figure 57. DNase I Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart